Earlier detection and treatment of non-alcoholic fatty liver disease: an economic evaluation to appraise an innovative diagnostic pathway to detect and intervene …

L Tanajewski, R Harris, D Harman, N Guha… - Value in …, 2015 - valueinhealthjournal.com
Objectives The prevalence of liver disease is increasing and often remains undetected until
the late stages. The study estimated cost-effectiveness of an innovative diagnostic pathway
(IDP) targeting adults with risk factors of non-alcoholic fatty liver disease (NAFLD) from an
NHS England perspective. Methods Economic evaluation compared IDP (algorithm applied
in a general practice to identify adults with risk factors for NAFLD, then stratifying disease
severity using a Fibroscan to test liver stiffness, followed by hepatologist-led treatment …
以上显示的是最相近的搜索结果。 查看全部搜索结果